NOVORAPID PENFILL 100 U / ML
insuline asparte
Public price
497,00 MAD
Active substance
insuline asparte
Laboratory
LAPROPHAN
What is this medicine?
NOVORAPID PENFILL 100 U / ML: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient.
Verified summary
insuline asparte, Solution injectable, 100 U / ML, Boîte de 5 cartouches de 3 ml
Common uses
Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Diabetology - antidiabetic
Laboratory
LAPROPHAN
Hospital price
330,00 MAD
Strength
100 U / ML
Form
Solution injectable
Presentation
Boîte de 5 cartouches de 3 ml
ATC code
A10AB05
Type
Générique
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 497,00 MAD
Medicines with the same active substance
NOVOMIX 30 FLEXPEN 100 U / ML
100 U / ML · Boîte de 5 stylos pré/remplis de 3 ml
559,00 MAD
FIASP
100 U / ML · BOITE D’UN FLACON DE 10 ML DE SOLUTION
Not available in the verified source
FIASP FLEXTOUCH
100 U / ML · BOITE DE 1 STYLO DE 3 ML DE SOLUTION
Not available in the verified source
FIASP FLEXTOUCH
100 U / ML · BOITE DE 5 STYLOS DE 3 ML DE SOLUTION
Not available in the verified source
FIASP PENFILL
100 U / ML · BOITE DE 5 CARTOUCHES DE 3 ML DE SOLUTION
Not available in the verified source